Wealthstar Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Wealthstar Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$55K	Hold	73,295	–	–	0.04%	62
2019 Q4	$111K	Hold	73,295	–	–	0.07%	67
2019 Q3	$108K	Hold	73,295	–	–	0.06%	65
2019 Q2	$95K	Hold	73,295	–	–	0.06%	65
2019 Q1	$192K	Hold	73,295	–	–	0.12%	57
2018 Q4	$121K	Hold	73,295	–	–	0.09%	55
2018 Q3	$355K	Hold	73,295	–	–	0.21%	40
2018 Q2	$418K	Hold	73,295	–	–	0.13%	33
2018 Q1	$608K	Buy	+73,295	New	+$700K	0.18%	20

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wealthstar Advisors's NEOS Position: Q1 2020 in Review

Wealthstar Advisors held its Neos Therapeutics, Inc (NEOS) position steady in Q1 2020 at 73,295 shares worth $55K. The position accounts for 0.04% of the portfolio, ranked #62.

Wealthstar Advisors first reported a position in NEOS in Q1 2018 and has held it in 9 quarters since. The position peaked at $608K in Q1 2018. 49 funds tracked by Wall St. Rank hold NEOS as of Q1 2020.

Wealthstar Advisors held 73,295 shares of Neos Therapeutics, Inc worth $55K as of Q1 2020.
Wealthstar Advisors left its Neos Therapeutics, Inc share count unchanged in Q1 2020.
Neos Therapeutics, Inc made up 0.04% of Wealthstar Advisors's portfolio in Q1 2020, its #62 holding.
Wealthstar Advisors first reported a position in Neos Therapeutics, Inc in Q1 2018 and has held it in 9 quarters since.
Wealthstar Advisors's Neos Therapeutics, Inc position peaked at $608K in Q1 2018.
49 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2020.

Based on Wealthstar Advisors's 13F filing for Q1 2020, filed 12 May 2020.